SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-21-007862
Filing Date
2021-04-09
Accepted
2021-04-09 16:15:54
Documents
1
Period of Report
2021-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3990
  Complete submission text file 0001567619-21-007862.txt   5353
Mailing Address 780 THIRD AVENUE, 12TH FLOOR NEW YORK NY 10017
Business Address
Bernstein Bruce (Reporting) CIK: 0001665472 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39752 | Film No.: 21818023

Mailing Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015
Business Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015 301-215-7440
Petros Pharmaceuticals, Inc. (Issuer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations